
Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls

Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls


The rise in product volume is more than matched by the rise of regulatory constraints

A 'performance curve' chart for containers could simplify the design process


Design analysis can dictate blister composition


Looking at the essential value of well-managed supply chains

IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets

Office of Prescription Drug Promotion finds little to complain about

HDMA seeks to encourage more outreach to business partners and government

Despite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay


'Average Manufacturer Price' is now a mostly settled matter

Agency plans new guidance in traceability, REMS and biosimilarity, among others

Sonoco ThermoSafe's device provides 120 hours of on-spec performance

rfXcel and Covectra announce new versions of their DSCSA-compliant software

Personalized Medicine Coalition notes uptick in diagnostic-influenced drug approvals

Pharmacies sue PBMs for restraint of trade, while payers question their activities

Deal value soared above $300 billion in 2015, but will the dealmaking sustain Big Pharma companies?

Industry is doing better at filing studies, but the agency is falling behind reviews, says GAO

A 'moon shot' to cure cancer is part of Obama's last Address

Controlled environment protects cold chain shipments in transit

Construction index shows a steady level of North American activity

ZIMonitor tracking service provides remote monitoring

'Innovation' is the recurring theme

HDMA's 2015-16 Factbook updates member financial, operational performance

Combination expands breadth of commercialization and compliance services

List includes 21 new orphan drugs, and of the 45, 15 are cold chain products

Innomar unit acquires Cameron Stewart LifeScience (CSL), provider of copay cards